$PRTK Paratek Pharmaceuticals, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Paratek Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Paratek Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Paratek Pharmaceuticals, Inc. for free.

CIK Number: 0001178711
IRS Number: 330960223
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: PRTK
Company Address: 75 PARK PLAZA 4TH FLOOR BOSTON 02116
Former name: NOVACEA INC, date of change: 2002-07-24
Former name: Transcept Pharmaceuticals Inc, date of change: 2009-01-30

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.

Market Capitalization: $346.19M
Prev close: $15.25
Average Daily Volume: 160,755
Days Low: $15.05
Year Low: $9.80
Year High: $18.92

Paratek Pharmaceuticals, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
BIGHAM MICHAELExec. Chairman of the Board827,76712,623,447shares bought: 969,005 / shares sold: -206,838 STRONG BUYApr 01 20211 month ago
Brenner Randall B.Chief Development & Regulatory250,2823,816,801shares bought: 199,750 / shares sold: -48,480 STRONG BUYApr 01 20211 month ago
Dietz Thomas JohnDirector30,000457,500shares bought: 39,000 / shares sold: -14,430 STRONG BUYFeb 22 20212 months ago
Franson Timothy RDirector39,000594,750shares bought: 39,000 / shares sold: 0 STRONG BUYFeb 22 20212 months ago
Haskel William M.CLO, General Counsel & Sec.336,0175,124,259shares bought: 375,875 / shares sold: -63,912 STRONG BUYApr 01 20211 month ago
Hoffmann Rolf KDirector44,000671,000shares bought: 40,500 / shares sold: 0 STRONG BUYFeb 22 20212 months ago
Loh EvanCEO904,30913,790,712shares bought: 1,208,102 / shares sold: -193,971 STRONG BUYApr 01 20211 month ago
Peterson KristineDirector39,000594,750shares bought: 39,000 / shares sold: 0 STRONG BUYFeb 22 20212 months ago
Radie Robert SDirector32,250491,813shares bought: 39,000 / shares sold: -10,500 STRONG BUYFeb 22 20212 months ago
Stein JeffreyDirector35,625543,281shares bought: 39,000 / shares sold: -6,750 STRONG BUYFeb 22 20212 months ago
Woodrow AdamPresident & Chief Commercial449,0236,847,601shares bought: 502,250 / shares sold: -107,404 STRONG BUYApr 01 20211 month ago

View all Paratek Pharmaceuticals, Inc. insiders.

Paratek Pharmaceuticals, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 01 2021PRTKParatek Pharmaceut ...Loh EvanCEOGrantA0.00303,7500904,309600.6 K to 904.3 K (+50.58 %)
Apr 01 2021PRTKParatek Pharmaceut ...Brenner Randall B.Chief Development & ...GrantA0.00121,5000250,282128.8 K to 250.3 K (+94.35 %)
Apr 01 2021PRTKParatek Pharmaceut ...Haskel William M.CLO, General Counse ...GrantA0.00132,7500336,017203.3 K to 336 K (+65.31 %)
Apr 01 2021PRTKParatek Pharmaceut ...BIGHAM MICHAELExec. Chairman of t ...GrantA0.00281,2500827,767546.5 K to 827.8 K (+51.46 %)
Apr 01 2021PRTKParatek Pharmaceut ...Woodrow AdamPresident & Chief C ...GrantA0.00177,7500449,023271.3 K to 449 K (+65.52 %)
Feb 22 2021PRTKParatek Pharmaceut ...Stein JeffreyDirectorOption ExerciseA7.617,00053,2707,000
Feb 22 2021PRTKParatek Pharmaceut ...Stein JeffreyDirectorGrantA0.009,000035,62526.6 K to 35.6 K (+33.80 %)
Feb 22 2021PRTKParatek Pharmaceut ...Radie Robert SDirectorOption ExerciseA7.617,00053,2707,000
Feb 22 2021PRTKParatek Pharmaceut ...Radie Robert SDirectorGrantA0.009,000032,25023.3 K to 32.3 K (+38.71 %)
Feb 22 2021PRTKParatek Pharmaceut ...Peterson KristineDirectorOption ExerciseA7.617,00053,2707,000
Feb 22 2021PRTKParatek Pharmaceut ...Peterson KristineDirectorGrantA0.009,000039,00030 K to 39 K (+30.00 %)
Feb 22 2021PRTKParatek Pharmaceut ...Hoffmann Rolf KDirectorOption ExerciseA7.617,00053,2707,000
Feb 22 2021PRTKParatek Pharmaceut ...Hoffmann Rolf KDirectorGrantA0.009,000044,00035 K to 44 K (+25.71 %)
Feb 22 2021PRTKParatek Pharmaceut ...Franson Timothy RDirectorOption ExerciseA7.617,00053,2707,000
Feb 22 2021PRTKParatek Pharmaceut ...Franson Timothy RDirectorGrantA0.009,000039,00030 K to 39 K (+30.00 %)

View all Paratek Pharmaceuticals, Inc. insider transactions.